Search Results - "Cottam, Howard B."

Refine Results
  1. 1
  2. 2

    Structure–Activity Relationship Studies of Pyrimido[5,4‑b]indoles as Selective Toll-Like Receptor 4 Ligands by Chan, Michael, Kakitsubata, Yuhei, Hayashi, Tomoko, Ahmadi, Alast, Yao, Shiyin, Shukla, Nikunj M, Oyama, Shin-ya, Baba, Akihito, Nguyen, Brandon, Corr, Maripat, Suda, Yasuo, Carson, Dennis A, Cottam, Howard B, Wakao, Masahiro

    Published in Journal of medicinal chemistry (22-11-2017)
    “…Previous high throughput screening studies led to the discovery of two novel, nonlipid-like chemotypes as Toll-like receptor 4 (TLR4) agonists. One of these…”
    Get full text
    Journal Article
  3. 3

    Enhancement of the Immunostimulatory Activity of a TLR7 Ligand by Conjugation to Polysaccharides by Shinchi, Hiroyuki, Crain, Brian, Yao, Shiyin, Chan, Michael, Zhang, Shannon S, Ahmadiiveli, Alast, Suda, Yasuo, Hayashi, Tomoko, Cottam, Howard B, Carson, Dennis A

    Published in Bioconjugate chemistry (19-08-2015)
    “…Toll-like receptors (TLRs) in the innate immune system recognize specific pathogen-associated molecular patterns derived from microbes. Synthetic small…”
    Get full text
    Journal Article
  4. 4

    Identification of Substituted Pyrimido[5,4‑b]indoles as Selective Toll-Like Receptor 4 Ligands by Chan, Michael, Hayashi, Tomoko, Mathewson, Richard D, Nour, Afshin, Hayashi, Yuki, Yao, Shiyin, Tawatao, Rommel I, Crain, Brian, Tsigelny, Igor F, Kouznetsova, Valentina L, Messer, Karen, Pu, Minya, Corr, Maripat, Carson, Dennis A, Cottam, Howard B

    Published in Journal of medicinal chemistry (13-06-2013)
    “…A cell-based high-throughput screen to identify small molecular weight stimulators of the innate immune system revealed substituted pyrimido­[5,4-b]­indoles as…”
    Get full text
    Journal Article
  5. 5

    Nrf2 responses and the therapeutic selectivity of electrophilic compounds in chronic lymphocytic leukemia by Wu, Raymond P., Hayashi, Tomoko, Cottam, Howard B., Jin, Guangyi, Yao, Shiyin, Wu, Christina C. N., Rosenbach, Michael D., Corr, Maripat, Schwab, Richard B., Carson, Dennis A.

    “…Recent studies show that redox-active small molecules are selectively cytotoxic to chronic lymphocytic leukemia (CLL). Although elevated levels of reactive…”
    Get full text
    Journal Article
  6. 6

    Synthesis and immunostimulatory activity of sugar-conjugated TLR7 ligands by Baba, Akihito, Wakao, Masahiro, Shinchi, Hiroyuki, Chan, Michael, Hayashi, Tomoko, Yao, Shiyin, Cottam, Howard B., Carson, Dennis A., Suda, Yasuo

    Published in Bioorganic & medicinal chemistry letters (01-02-2020)
    “…[Display omitted] Toll-like receptors (TLRs) are a type of pattern recognition receptors (PRRs), which are activated by recognizing pathogen-associated…”
    Get full text
    Journal Article
  7. 7

    Molecular Basis for the Immunostimulatory Activity of Guanine Nucleoside Analogs: Activation of Toll-like Receptor 7 by Lee, Jongdae, Chuang, Tsung-Hsien, Redecke, Vanessa, She, Liping, Pitha, Paula M., Carson, Dennis A., Raz, Eyal, Cottam, Howard B.

    “…Certain C8-substituted and N7, C8-disubstituted guanine ribonucleosides comprise a class of small molecules with immunostimulatory activity. In a variety of…”
    Get full text
    Journal Article
  8. 8

    Generation and Application of a Reporter Cell Line for the Quantitative Screen of Extracellular Vesicle Release by Shpigelman, Jonathan, Lao, Fitzgerald S, Yao, Shiyin, Li, Chenyang, Saito, Tetsuya, Sato-Kaneko, Fumi, Nolan, John P, Shukla, Nikunj M, Pu, Minya, Messer, Karen, Cottam, Howard B, Carson, Dennis A, Corr, Maripat, Hayashi, Tomoko

    Published in Frontiers in pharmacology (16-04-2021)
    “…Extracellular vesicles (EVs) are identified as mediators of intercellular communication and cellular regulation. In the immune system, EVs play a role in…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Induction of Tolerogenic Dendritic Cells by a PEGylated TLR7 Ligand for Treatment of Type 1 Diabetes by Hayashi, Tomoko, Yao, Shiyin, Crain, Brian, Promessi, Victor J, Shyu, Luke, Sheng, Caroline, Kang, McNancy, Cottam, Howard B, Carson, Dennis A, Corr, Maripat

    Published in PloS one (15-06-2015)
    “…Autoimmune diabetes mellitus (DM) results from the destruction of pancreatic islet cells by activated T lymphocytes, which have been primed by activated…”
    Get full text
    Journal Article
  11. 11

    Co-Delivery of a Novel Lipidated TLR7/8 Agonist and Hemagglutinin-Based Influenza Antigen Using Silica Nanoparticles Promotes Enhanced Immune Responses by Abdelwahab, Walid M, Auclair, Sarah, Borgogna, Timothy, Siram, Karthik, Riffey, Alexander, Bazin, Hélène G, Cottam, Howard B, Hayashi, Tomoko, Evans, Jay T, Burkhart, David J

    Published in Pharmaceutics (01-01-2024)
    “…Co-delivery of antigens and adjuvants to the same antigen-presenting cells (APCs) can significantly improve the efficacy and safety profiles of vaccines. Here,…”
    Get full text
    Journal Article
  12. 12

    Activation of the Wnt Signaling Pathway in Chronic Lymphocytic Leukemia by Lu, Desheng, Zhao, Yandong, Tawatao, Rommel, Cottam, Howard B., Sen, Malini, Leoni, Lorenzo M., Kipps, Thomas J., Corr, Maripat, Carson, Dennis A.

    “…B cell chronic lymphocytic leukemia (CLL) is characterized by an accumulation of mature, functionally incompetent B cells. Wnts are a large family of secreted…”
    Get full text
    Journal Article
  13. 13

    A Triple High Throughput Screening for Extracellular Vesicle Inducing Agents With Immunostimulatory Activity by Shukla, Nikunj M, Sato-Kaneko, Fumi, Yao, Shiyin, Pu, Minya, Chan, Michael, Lao, Fitzgerald S, Sako, Yukiya, Saito, Tetsuya, Messer, Karen, Hayashi, Tomoko, Cottam, Howard B, Corr, Maripat, Carson, Dennis A

    Published in Frontiers in pharmacology (11-04-2022)
    “…Extracellular vesicles (EVs) play an important role in intercellular communication and regulation of cells, especially in the immune system where EVs can…”
    Get full text
    Journal Article
  14. 14

    Small Molecule Potentiator of Adjuvant Activity Enhancing Survival to Influenza Viral Challenge by Saito, Tetsuya, Sako, Yukiya, Sato-Kaneko, Fumi, Hosoya, Tadashi, Yao, Shiyin, Lao, Fitzgerald S, Shpigelman, Jonathan, Messer, Karen, Pu, Minya, Shukla, Nikunj M, Chan, Michael, Chu, Paul J, Cottam, Howard B, Hayashi, Tomoko, Carson, Dennis A, Corr, Maripat

    Published in Frontiers in immunology (28-09-2021)
    “…As viruses continue to mutate the need for rapid high titer neutralizing antibody responses has been highlighted. To meet these emerging threats, agents that…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Synthesis and Immunological Characterization of Toll-Like Receptor 7 Agonistic Conjugates by Chan, Michael, Hayashi, Tomoko, Kuy, Crystal S, Gray, Christine S, Wu, Christina C. N, Corr, Maripat, Wrasidlo, Wolfgang, Cottam, Howard B, Carson, Dennis A

    Published in Bioconjugate chemistry (17-06-2009)
    “…Activation of toll-like receptors (TLRs) on cells of the innate immune system initiates, amplifies, and directs the antigen-specific acquired immune response…”
    Get full text
    Journal Article
  17. 17

    Activation of Anti-Hepatitis C Virus Responses via Toll-like Receptor 7 by Lee, Jongdae, Wu, Christina C. N., Lee, Ki Jeong, Chuang, Tsung-Hsien, Katakura, Kyoko, Liu, Yu-Tsueng, Chan, Michael, Tawatao, Rommel, Chung, Michelle, Shen, Carol, Cottam, Howard B., Lai, Michael M. C., Raz, Eyal, Carson, Dennis A.

    “…IFN-α is used to suppress the replication of hepatitis C virus (HCV) in chronically infected patients with partial success. Here we present evidence showing…”
    Get full text
    Journal Article
  18. 18

    A Dual Adjuvant System for Intranasal Boosting of Local and Systemic Immunity for Influenza Vaccination by Sato-Kaneko, Fumi, Yao, Shiyin, Lao, Fitzgerald S, Sako, Yukiya, Jin, Jasmine, Shukla, Nikunj M, Cottam, Howard B, Chan, Michael, Belsuzarri, Masiel M, Carson, Dennis A, Hayashi, Tomoko

    Published in Vaccines (Basel) (01-10-2022)
    “…Systemically vaccinated individuals against COVID-19 and influenza may continue to support viral replication and shedding in the upper airways, contributing to…”
    Get full text
    Journal Article
  19. 19

    Immunotherapeutic activity of a conjugate of a Toll-like receptor 7 ligand by Wu, Christina C.N, Hayashi, Tomoko, Takabayashi, Kenji, Sabet, Mojgan, Smee, Donald F, Guiney, Donald D, Cottam, Howard B, Carson, Dennis A

    “…The immunotherapeutic activity of Toll-like receptor (TLR) activators has been difficult to exploit because of side effects related to the release and systemic…”
    Get full text
    Journal Article
  20. 20

    Treatment of autoimmune inflammation by a TLR7 ligand regulating the innate immune system by Hayashi, Tomoko, Yao, Shiyin, Crain, Brian, Chan, Michael, Tawatao, Rommel I, Gray, Christine, Vuong, Linda, Lao, Fitzgerald, Cottam, Howard B, Carson, Dennis A, Corr, Maripat

    Published in PloS one (28-09-2012)
    “…The Toll-like receptors (TLR) have been advocated as attractive therapeutic targets because TLR signaling plays dual roles in initiating adaptive immune…”
    Get full text
    Journal Article